Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Bradley Martin

Concepts (373)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Analgesics, Opioid
43
2024
591
8.600
Why?
Chronic Pain
17
2024
178
5.840
Why?
Opioid-Related Disorders
17
2024
400
4.040
Why?
Drug Overdose
11
2024
165
3.850
Why?
Medicaid
23
2021
264
2.700
Why?
Drug Prescriptions
15
2024
103
2.610
Why?
Tramadol
3
2024
30
2.380
Why?
Alcoholism
4
2022
240
2.370
Why?
Antipsychotic Agents
10
2018
235
1.930
Why?
Retrospective Studies
45
2025
6671
1.790
Why?
Anticoagulants
7
2025
279
1.710
Why?
Adult
59
2025
14170
1.710
Why?
Middle Aged
59
2025
13096
1.660
Why?
United States
53
2024
5227
1.650
Why?
Humans
112
2025
52593
1.570
Why?
Osteoarthritis, Knee
3
2017
97
1.470
Why?
Pain
11
2022
362
1.460
Why?
Health Care Costs
10
2022
176
1.340
Why?
Young Adult
29
2025
4337
1.330
Why?
Female
74
2025
28262
1.320
Why?
Adolescent
38
2024
6737
1.300
Why?
Aged
44
2025
10191
1.290
Why?
Male
70
2025
26863
1.280
Why?
Atrial Fibrillation
4
2016
201
1.230
Why?
Viscosupplements
3
2017
14
1.220
Why?
Asthma
4
2017
317
1.200
Why?
Hyaluronic Acid
3
2017
38
1.200
Why?
Mental Disorders
7
2025
428
1.170
Why?
Medication Adherence
6
2016
133
1.150
Why?
Emergency Service, Hospital
6
2016
524
1.110
Why?
Schizophrenia
5
2009
254
1.080
Why?
Cross-Over Studies
2
2025
239
1.070
Why?
Cohort Studies
17
2024
1553
1.040
Why?
Arthroplasty, Replacement, Knee
4
2017
289
1.030
Why?
Analgesics, Non-Narcotic
3
2012
117
1.020
Why?
Substance-Related Disorders
5
2021
609
1.000
Why?
Acetaminophen
4
2015
279
1.000
Why?
Warfarin
4
2016
84
0.980
Why?
Venous Thromboembolism
2
2025
76
0.980
Why?
Patient Compliance
6
2009
230
0.970
Why?
Veterans
10
2024
581
0.930
Why?
Psychotropic Drugs
1
2025
77
0.890
Why?
Psychotherapy
1
2025
113
0.860
Why?
Suicide
1
2025
85
0.840
Why?
Prescription Drugs
6
2014
41
0.830
Why?
Cost-Benefit Analysis
5
2020
269
0.820
Why?
Insurance, Health
7
2020
133
0.790
Why?
Risk Factors
15
2025
3952
0.770
Why?
Attention Deficit Disorder with Hyperactivity
1
2023
178
0.750
Why?
Neck Pain
2
2021
10
0.750
Why?
Back Pain
2
2021
39
0.730
Why?
Arkansas
14
2024
2029
0.730
Why?
Drug Utilization
11
2017
77
0.730
Why?
Central Nervous System Stimulants
1
2023
206
0.720
Why?
Arthralgia
1
2021
44
0.710
Why?
Hospitalization
6
2016
749
0.700
Why?
Professional-Patient Relations
1
2021
47
0.700
Why?
Insurance, Pharmaceutical Services
2
2019
25
0.690
Why?
Decision Support Techniques
3
2016
71
0.690
Why?
Stroke
3
2016
515
0.690
Why?
Logistic Models
8
2016
934
0.660
Why?
Narcotic Antagonists
2
2024
139
0.660
Why?
Naloxone
1
2020
79
0.630
Why?
Breast Neoplasms
4
2023
1205
0.620
Why?
Hydrocodone
3
2024
20
0.620
Why?
Oxycodone
3
2024
26
0.620
Why?
Legislation, Drug
1
2019
18
0.610
Why?
Contraception
1
2019
30
0.600
Why?
Proton Pump Inhibitors
2
2016
86
0.590
Why?
Adrenal Cortex Hormones
2
2017
114
0.570
Why?
Follow-Up Studies
8
2024
2291
0.550
Why?
Guidelines as Topic
1
2018
110
0.550
Why?
Mammography
1
2018
97
0.550
Why?
Buprenorphine
3
2024
151
0.550
Why?
Practice Guidelines as Topic
3
2017
496
0.540
Why?
Histamine H2 Antagonists
1
2016
26
0.530
Why?
Peptic Ulcer
1
2016
14
0.530
Why?
Purinergic P2Y Receptor Antagonists
3
2022
35
0.500
Why?
Education, Pharmacy, Graduate
1
2016
20
0.500
Why?
Pyridones
1
2016
36
0.500
Why?
Risk
4
2020
313
0.490
Why?
Inappropriate Prescribing
1
2016
23
0.490
Why?
Safety-Based Drug Withdrawals
1
2015
7
0.480
Why?
Dextropropoxyphene
1
2015
6
0.480
Why?
Insurance Claim Review
5
2010
40
0.480
Why?
Health Expenditures
3
2011
74
0.480
Why?
Tobacco Use Cessation
1
2015
10
0.480
Why?
For-Profit Insurance Plans
1
2015
2
0.480
Why?
Databases, Factual
11
2022
715
0.470
Why?
Brain Ischemia
2
2016
162
0.470
Why?
Pyrazoles
1
2016
114
0.470
Why?
Mass Screening
1
2018
358
0.460
Why?
Quinolines
1
2015
44
0.460
Why?
Acetates
1
2015
52
0.450
Why?
Time Factors
9
2018
3000
0.450
Why?
Opiate Substitution Treatment
3
2024
102
0.450
Why?
Stress, Psychological
1
2016
273
0.450
Why?
Diabetic Neuropathies
1
2015
56
0.450
Why?
Anticonvulsants
2
2006
134
0.450
Why?
Insurance Claim Reporting
2
2011
11
0.440
Why?
Low Back Pain
2
2025
31
0.440
Why?
Critical Illness
1
2016
312
0.440
Why?
Controlled Substances
2
2024
7
0.430
Why?
Curriculum
2
2018
399
0.430
Why?
Pain Management
1
2015
179
0.420
Why?
Palliative Care
1
2016
216
0.420
Why?
Tobacco Products
1
2015
127
0.420
Why?
Aged, 80 and over
13
2023
3420
0.420
Why?
Injections, Intra-Articular
3
2017
38
0.400
Why?
Computers, Handheld
1
2013
23
0.400
Why?
Neoplasms
1
2023
1308
0.400
Why?
Prescription Drug Misuse
3
2024
33
0.400
Why?
Evidence-Based Medicine
3
2014
269
0.400
Why?
United States Department of Veterans Affairs
5
2024
293
0.390
Why?
Neuralgia
2
2023
43
0.390
Why?
Quality-Adjusted Life Years
3
2020
67
0.380
Why?
Age Factors
6
2018
1132
0.380
Why?
Benzodiazepines
3
2024
72
0.380
Why?
Cross-Sectional Studies
6
2022
1686
0.370
Why?
Health Knowledge, Attitudes, Practice
1
2015
510
0.350
Why?
Case-Control Studies
7
2023
1202
0.350
Why?
Community Pharmacy Services
3
2020
66
0.350
Why?
Medicare
6
2023
274
0.330
Why?
Health Personnel
1
2013
252
0.330
Why?
Kidney Failure, Chronic
2
2022
216
0.320
Why?
Employment
2
2015
93
0.310
Why?
Age Distribution
5
2018
175
0.310
Why?
Motor Vehicles
1
2009
14
0.310
Why?
Antidepressive Agents
2
2009
177
0.310
Why?
Automobile Driving
1
2009
27
0.300
Why?
Propensity Score
3
2022
158
0.300
Why?
Medication Errors
1
2009
25
0.300
Why?
Pharmacists
3
2019
141
0.300
Why?
Hemorrhage
3
2023
224
0.290
Why?
Prevalence
5
2018
1017
0.290
Why?
Cost of Illness
3
2013
120
0.290
Why?
Physicians, Primary Care
2
2018
46
0.290
Why?
Pain Measurement
6
2021
257
0.280
Why?
Health Resources
2
2012
72
0.280
Why?
College Admission Test
2
2018
13
0.280
Why?
Antimanic Agents
1
2007
14
0.270
Why?
School Admission Criteria
2
2018
35
0.270
Why?
Schools, Pharmacy
2
2018
56
0.260
Why?
Markov Chains
2
2020
30
0.260
Why?
Georgia
6
2006
42
0.260
Why?
Pharmaceutical Services
2
2018
52
0.260
Why?
Child
10
2019
7229
0.260
Why?
Constipation
1
2006
37
0.260
Why?
Orthopedic Procedures
2
2017
71
0.260
Why?
Hypoglycemic Agents
1
2008
217
0.260
Why?
Overweight
1
2009
224
0.260
Why?
Postoperative Complications
2
2025
1081
0.260
Why?
Multivariate Analysis
4
2017
602
0.250
Why?
Least-Squares Analysis
4
2011
44
0.250
Why?
United States Food and Drug Administration
4
2011
96
0.250
Why?
Knee Joint
2
2017
165
0.250
Why?
Platelet Aggregation Inhibitors
2
2021
213
0.240
Why?
Students, Pharmacy
2
2018
125
0.240
Why?
Odds Ratio
4
2020
568
0.240
Why?
Risperidone
2
2010
25
0.230
Why?
Colectomy
1
2025
35
0.230
Why?
North Carolina
5
2011
56
0.230
Why?
Polypharmacy
1
2004
15
0.230
Why?
Drug Costs
2
2020
39
0.220
Why?
General Practitioners
1
2023
4
0.220
Why?
Severity of Illness Index
3
2017
1037
0.210
Why?
Patient Selection
1
2025
266
0.210
Why?
Haloperidol
1
2003
46
0.210
Why?
Renal Dialysis
2
2022
191
0.210
Why?
Direct Service Costs
1
2003
5
0.200
Why?
Motivation
1
2025
282
0.200
Why?
Irritable Bowel Syndrome
1
2003
17
0.200
Why?
Aftercare
1
2023
72
0.200
Why?
Dose-Response Relationship, Drug
5
2014
1378
0.200
Why?
Premedication
1
2002
18
0.200
Why?
Health Services Needs and Demand
1
2004
159
0.190
Why?
Diabetes Mellitus, Type 2
1
2008
567
0.190
Why?
Common Cold
1
2002
5
0.190
Why?
Bronchitis
1
2002
10
0.190
Why?
Advisory Committees
3
2018
71
0.190
Why?
Thromboembolism
1
2002
51
0.190
Why?
Proportional Hazards Models
4
2017
444
0.190
Why?
Accidents
1
2021
21
0.190
Why?
Respiratory Insufficiency
1
2023
117
0.180
Why?
Carcinoma, Non-Small-Cell Lung
1
2023
169
0.180
Why?
Depressive Disorder, Major
2
2020
148
0.180
Why?
Forecasting
3
2009
154
0.180
Why?
Colorectal Neoplasms
1
2025
295
0.180
Why?
Ambulatory Care Facilities
1
2002
124
0.180
Why?
Mental Health Services
1
2004
212
0.180
Why?
Respiratory Tract Infections
1
2002
82
0.170
Why?
Delivery of Health Care
2
2021
324
0.170
Why?
Patient Discharge
1
2023
326
0.170
Why?
Interprofessional Relations
2
2018
91
0.170
Why?
Afghan Campaign 2001-
2
2018
40
0.170
Why?
Regression Analysis
5
2013
403
0.170
Why?
Administration, Oral
2
2016
455
0.170
Why?
Obesity
1
2009
1165
0.170
Why?
Decision Making
5
2018
282
0.170
Why?
Administration, Intranasal
1
2020
31
0.170
Why?
Brain Neoplasms
1
2023
290
0.160
Why?
Economics, Pharmaceutical
2
2009
6
0.160
Why?
Cardiovascular Diseases
2
2018
495
0.160
Why?
Selection Bias
2
2009
15
0.160
Why?
Social Media
1
2022
117
0.160
Why?
Comparative Effectiveness Research
2
2009
47
0.160
Why?
Preventive Health Services
1
2020
52
0.160
Why?
Coronary Restenosis
1
2019
39
0.150
Why?
Child, Preschool
5
2011
4062
0.150
Why?
Drug Administration Schedule
3
2011
376
0.150
Why?
Guideline Adherence
3
2025
143
0.150
Why?
Sepsis
1
2021
234
0.150
Why?
Insurance Coverage
1
2020
115
0.150
Why?
Health Care Surveys
2
2011
177
0.150
Why?
Public Health Surveillance
1
2018
18
0.140
Why?
Sleep Deprivation
1
2018
18
0.140
Why?
Thiazoles
2
2016
54
0.140
Why?
Papillomavirus Vaccines
1
2019
69
0.140
Why?
Pharmacies
1
2019
60
0.140
Why?
Physicians
1
2021
241
0.140
Why?
Chronic Disease
5
2011
588
0.140
Why?
Metabolic Diseases
1
2018
47
0.140
Why?
Veterans Health
2
2014
64
0.140
Why?
Molecular Weight
1
2017
80
0.140
Why?
Acute Pain
1
2017
11
0.140
Why?
Lung Neoplasms
1
2023
634
0.140
Why?
Papillomavirus Infections
1
2019
172
0.130
Why?
Coronary Vessels
1
2019
173
0.130
Why?
Fractional Flow Reserve, Myocardial
1
2019
127
0.130
Why?
Educational Measurement
1
2018
198
0.130
Why?
Coronary Angiography
1
2019
388
0.130
Why?
Treatment Outcome
7
2010
5486
0.130
Why?
Eosinophils
1
2017
44
0.130
Why?
Monte Carlo Method
1
2016
88
0.130
Why?
Early Detection of Cancer
1
2018
183
0.130
Why?
Chilaiditi Syndrome
1
2015
1
0.120
Why?
Education, Pharmacy
1
2018
151
0.120
Why?
Anti-Bacterial Agents
1
2002
803
0.120
Why?
Incidental Findings
1
2015
43
0.120
Why?
India
1
2015
64
0.120
Why?
Health Services Accessibility
1
2020
438
0.120
Why?
Geriatrics
1
2016
47
0.120
Why?
Sex Distribution
1
2015
138
0.120
Why?
Health Policy
3
2011
158
0.120
Why?
Sulfides
1
2015
29
0.120
Why?
Models, Theoretical
1
2016
182
0.120
Why?
Cyclopropanes
1
2015
27
0.120
Why?
Pyridines
1
2016
134
0.120
Why?
Income
1
2015
103
0.120
Why?
Thrombosis
1
2018
262
0.110
Why?
Anti-Asthmatic Agents
1
2015
33
0.110
Why?
Sarcopenia
1
2015
98
0.110
Why?
Coronary Artery Disease
1
2019
320
0.110
Why?
Societies, Medical
1
2016
202
0.110
Why?
Renal Insufficiency, Chronic
1
2018
203
0.110
Why?
Self Report
1
2016
215
0.110
Why?
Long-Term Care
3
2012
51
0.110
Why?
Educational Status
1
2015
228
0.110
Why?
Enoxaparin
2
2025
31
0.110
Why?
Disease Progression
1
2017
873
0.110
Why?
California
2
2004
90
0.110
Why?
Comorbidity
5
2017
631
0.110
Why?
Health Literacy
1
2015
132
0.100
Why?
Health Behavior
1
2015
257
0.100
Why?
Prescriptions
2
2011
11
0.100
Why?
Monitoring, Physiologic
1
2013
123
0.100
Why?
Sensitivity and Specificity
1
2015
883
0.100
Why?
Risk Assessment
2
2015
1350
0.100
Why?
Drug Therapy, Combination
2
2004
400
0.090
Why?
Infant
3
2011
3720
0.090
Why?
Managed Care Programs
1
2012
36
0.090
Why?
Ticlopidine
1
2012
72
0.090
Why?
Predictive Value of Tests
2
2019
952
0.090
Why?
Randomized Controlled Trials as Topic
2
2025
600
0.090
Why?
Deductibles and Coinsurance
1
2011
2
0.090
Why?
Hypertension, Pulmonary
1
2012
119
0.080
Why?
Body Mass Index
2
2013
692
0.080
Why?
Calibration
1
2009
57
0.080
Why?
International Classification of Diseases
1
2009
67
0.080
Why?
Clozapine
2
2010
25
0.080
Why?
Analysis of Variance
1
2010
558
0.080
Why?
Reference Values
1
2009
313
0.080
Why?
Treatment Refusal
1
2009
35
0.080
Why?
Carbamazepine
1
2007
13
0.070
Why?
Lithium Compounds
1
2007
12
0.070
Why?
Mental Health
1
2010
240
0.070
Why?
Alendronate
1
2007
24
0.070
Why?
Valproic Acid
1
2007
35
0.070
Why?
Fractures, Spontaneous
1
2007
15
0.070
Why?
Internationality
3
2014
46
0.070
Why?
Osteoporosis, Postmenopausal
1
2007
29
0.070
Why?
Chemotherapy, Adjuvant
1
2007
124
0.070
Why?
Affect
1
2007
104
0.070
Why?
Drug Labeling
1
2006
11
0.060
Why?
Bone Density Conservation Agents
1
2007
75
0.060
Why?
Data Collection
2
2009
289
0.060
Why?
Adrenergic beta-Agonists
1
2005
42
0.060
Why?
Self Disclosure
1
2005
12
0.060
Why?
Australia
1
2025
90
0.060
Why?
Multicenter Studies as Topic
1
2025
112
0.060
Why?
Drug Interactions
2
2018
205
0.060
Why?
Depression
1
2009
604
0.060
Why?
Factor Analysis, Statistical
1
2004
86
0.060
Why?
Eligibility Determination
1
2004
21
0.060
Why?
Urban Population
1
2005
162
0.060
Why?
Health Surveys
2
2018
238
0.060
Why?
Prescription Fees
1
2004
14
0.050
Why?
Length of Stay
1
2007
674
0.050
Why?
Algorithms
1
2007
668
0.050
Why?
Laparoscopy
1
2025
181
0.050
Why?
Data Interpretation, Statistical
3
2009
164
0.050
Why?
MEDLINE
1
2002
8
0.050
Why?
SEER Program
1
2023
103
0.050
Why?
Prospective Studies
1
2008
2457
0.050
Why?
Cognition Disorders
1
2003
196
0.050
Why?
Antidepressive Agents, Second-Generation
1
2002
27
0.050
Why?
Neuropsychological Tests
1
2003
325
0.050
Why?
Analgesics
1
2023
106
0.050
Why?
Quality of Life
2
2023
882
0.050
Why?
Pharmacy
2
2018
55
0.050
Why?
Gastrointestinal Hemorrhage
1
2022
90
0.050
Why?
Longitudinal Studies
2
2014
747
0.040
Why?
Patient Protection and Affordable Care Act
1
2020
52
0.040
Why?
Needs Assessment
1
2020
139
0.040
Why?
Ohio
1
2019
45
0.040
Why?
Myocardial Revascularization
1
2019
30
0.040
Why?
Quality of Health Care
1
2020
188
0.040
Why?
Incidence
2
2014
1077
0.040
Why?
Pharmacoepidemiology
1
2017
8
0.030
Why?
Universities
1
2018
175
0.030
Why?
Research Design
2
2014
358
0.030
Why?
Vaccination
1
2019
299
0.030
Why?
Pilot Projects
1
2019
721
0.030
Why?
Communication
1
2018
257
0.030
Why?
Qualitative Research
1
2018
362
0.030
Why?
Electronic Health Records
1
2018
269
0.030
Why?
Attitude of Health Personnel
1
2018
361
0.030
Why?
Ischemic Attack, Transient
1
2013
59
0.020
Why?
Survival Analysis
1
2014
673
0.020
Why?
Lipids
1
2013
160
0.020
Why?
Linear Models
1
2013
292
0.020
Why?
Diagnosis, Dual (Psychiatry)
1
2012
41
0.020
Why?
Stress Disorders, Post-Traumatic
1
2017
401
0.020
Why?
Diagnostic Tests, Routine
1
2012
31
0.020
Why?
Cost Control
1
2011
13
0.020
Why?
Blood Pressure
1
2013
537
0.020
Why?
Acute Coronary Syndrome
1
2012
106
0.020
Why?
Blood Glucose
1
2013
473
0.020
Why?
Reproducibility of Results
2
2005
1217
0.020
Why?
Dibenzothiazepines
1
2010
10
0.020
Why?
Adolescent Behavior
1
2011
106
0.020
Why?
Hypnotics and Sedatives
1
2010
72
0.020
Why?
Off-Label Use
1
2010
24
0.020
Why?
Observation
1
2009
8
0.020
Why?
Epidemiologic Methods
1
2009
46
0.020
Why?
Causality
1
2009
52
0.020
Why?
Diabetes Mellitus
1
2013
318
0.020
Why?
Mood Disorders
1
2009
59
0.020
Why?
Quinolones
1
2010
50
0.020
Why?
Anxiety Disorders
1
2009
130
0.020
Why?
Piperazines
1
2010
125
0.020
Why?
ROC Curve
1
2009
254
0.020
Why?
Headache
1
2008
76
0.020
Why?
Sex Factors
1
2009
729
0.020
Why?
Confidence Intervals
1
2007
159
0.020
Why?
Probability
1
2007
173
0.020
Why?
Drug Utilization Review
1
2005
22
0.010
Why?
Drug Monitoring
1
2005
83
0.010
Why?
Bone Density
1
2007
399
0.010
Why?
Registries
1
2007
629
0.010
Why?
Health Maintenance Organizations
1
2002
16
0.010
Why?
Antidepressive Agents, Tricyclic
1
2002
28
0.010
Why?
Costs and Cost Analysis
1
2002
96
0.010
Why?
Martin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description